These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19495993)

  • 1. Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide.
    Kawatkar S; Wang H; Czerminski R; Joseph-McCarthy D
    J Comput Aided Mol Des; 2009 Aug; 23(8):527-39. PubMed ID: 19495993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual fragment screening: exploration of MM-PBSA re-scoring.
    Kawatkar S; Moustakas D; Miller M; Joseph-McCarthy D
    J Comput Aided Mol Des; 2012 Aug; 26(8):921-34. PubMed ID: 22869295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation.
    Loving K; Salam NK; Sherman W
    J Comput Aided Mol Des; 2009 Aug; 23(8):541-54. PubMed ID: 19421721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of compound libraries for fragment screening.
    Blomberg N; Cosgrove DA; Kenny PW; Kolmodin K
    J Comput Aided Mol Des; 2009 Aug; 23(8):513-25. PubMed ID: 19283339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of fragment docking and scoring with the endothiapepsin model system.
    Herbst C; Endres S; Würz R; Sotriffer C
    Arch Pharm (Weinheim); 2024 Jun; 357(6):e2400061. PubMed ID: 38631672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual fragment docking by Glide: a validation study on 190 protein-fragment complexes.
    Sándor M; Kiss R; Keseru GM
    J Chem Inf Model; 2010 Jun; 50(6):1165-72. PubMed ID: 20459088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Based Virtual Screening of Commercially Available Compound Libraries.
    Kireev D
    Methods Mol Biol; 2016; 1439():65-76. PubMed ID: 27316988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterisation of new inhibitors for the human hematopoietic prostaglandin D2 synthase.
    Weber JE; Oakley AJ; Christ AN; Clark AG; Hayes JD; Hall R; Hume DA; Board PG; Smythe ML; Flanagan JU
    Eur J Med Chem; 2010 Feb; 45(2):447-54. PubMed ID: 19939518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space.
    Rudling A; Gustafsson R; Almlöf I; Homan E; Scobie M; Warpman Berglund U; Helleday T; Stenmark P; Carlsson J
    J Med Chem; 2017 Oct; 60(19):8160-8169. PubMed ID: 28929756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations.
    Cuzzolin A; Sturlese M; Malvacio I; Ciancetta A; Moro S
    Molecules; 2015 May; 20(6):9977-93. PubMed ID: 26035098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
    Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
    J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
    Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
    J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons for fragment library design: analysis of output from multiple screening campaigns.
    Chen IJ; Hubbard RE
    J Comput Aided Mol Des; 2009 Aug; 23(8):603-20. PubMed ID: 19495994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-based virtual screening approach using a new scoring function.
    Hamza A; Wei NN; Zhan CG
    J Chem Inf Model; 2012 Apr; 52(4):963-74. PubMed ID: 22486340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking of small molecules to farnesoid X receptors using AutoDock Vina with the Convex-PL potential: lessons learned from D3R Grand Challenge 2.
    Kadukova M; Grudinin S
    J Comput Aided Mol Des; 2018 Jan; 32(1):151-162. PubMed ID: 28913782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structure and function of prostaglandin D synthase].
    Urade Y
    Tanpakushitsu Kakusan Koso; 2008 Mar; 53(3):217-26. PubMed ID: 18326294
    [No Abstract]   [Full Text] [Related]  

  • 18. Docking and Virtual Screening in Drug Discovery.
    Kontoyianni M
    Methods Mol Biol; 2017; 1647():255-266. PubMed ID: 28809009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and NMR validation of minimal pharmacophore hypotheses for the generation of fragment libraries enriched in heparanase inhibitors.
    Gozalbes R; Mosulén S; Carbajo RJ; Pineda-Lucena A
    J Comput Aided Mol Des; 2009 Aug; 23(8):555-69. PubMed ID: 19421720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology.
    Neumann L; Ritscher A; Müller G; Hafenbradl D
    J Comput Aided Mol Des; 2009 Aug; 23(8):501-11. PubMed ID: 19533372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.